Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia
1993 ◽
Vol 83
(1)
◽
pp. 28-29
◽
1996 ◽
Vol 9
(5)
◽
pp. 506-508
◽
2004 ◽
Vol 19
(8)
◽
pp. 2137-2139
◽
2005 ◽
Vol 20
(3)
◽
pp. 626-630
◽
1991 ◽
Vol 79
(1)
◽
pp. 125-125
◽
2003 ◽
Vol 33
(9-10)
◽
pp. 468-471
◽
2005 ◽
Vol 32
(2)
◽
pp. 97-100
◽